Effect of combined oral contraceptive containing 17β-estradiol on vaginal environment in women
https://doi.org/10.33667/2078-5631-2020-26-53-56
Abstract
Objective. To study the effect of a combined oral contraceptive (COC) containing 2.5 mg of nomegestrol acetate (NOMAC) and 1.5 mg of 17β-estradiol (E 2) (NOMAC-E 2) on microbiocenosis and status of the vaginal environment in women of reproductive age. Material and methods. The study involved 52 generally healthy women in need of contraception aged 18 to 49 years. The average age was 35.1 (3.9) years. Before and after 6 months of COC use the microbiocenosis, vaginal moisture and acidity (pH) have been determined, a correlation with the level of sex hormones in the blood has been performed. Results. After 6 months of using COC containing NOMAC-E 2 normal flora with a predominance of lactobacilli was determined in 50 (96.2 %) women. There was a significant increase in vaginal moisture, tendency to increase the acidity of vaginal environment has been obtained. The use of pairwise correlation method did not reveal any statistically significant relationships between the changes in pH values, vaginal moisture content and the level of sex hormones and SHBG level. Conclusion. The use of COC containing NOMAC-E 2 for 6 months does not have adversely effect on microbiocenosis and state of the vaginal environment in women of reproductive age.
About the Authors
R. I. Gabidullina
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
E. I. Galimyanova
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
A. M. Sharapova
Povolzhsky Centre of Oncodiagnostics
Russian Federation
Kazan
Russian Federation
Kazan
R. R. Bagirli
Kazan State Medical University
Russian Federation
Kazan
Russian Federation
Kazan
References
1. Прилепская В.Н. Эволюция контрацепции в России. // Медицинский оппонент. 2018. № 4. С. 16– 21. [Prilepskaya V.N. The evolution of contraception in Russia // Medical Opponent. 2018. N4. P. 16–21]
2. Кузнецова И.В. Индивидуальный выбор гормонального контрацептивного средства. // Медицинский алфавит. 2019. Т. 1. № 1 (376). С. 6–14. [Kuznetsova I. V. Individual choice of hormonal contraceptive. // Medical Alphabet. 2019. Vol. 1. N1 (376). P. 6–14.]
3. Fosch S.E., Ficoseco C.A., Marchesi A. et al. Contraception: Influence on Vaginal Microbiota and Identification of Vaginal Lactobacilli Using MALDI-TOF MS and 16S rDNA Sequencing. // The Open Microbiology Journal. 2018. Vol. 12. P. 218–229.
4. Sharon L. Achilles et al. Impact of contraceptive initiation on vaginal microbiota. // Am J Obstet Gynecol. 2018. Vol. 218. N6. P. 622.E1–622.E10.
5. Прилепская В. Н., Летуновская А. Б., Донников А.Е. Микробиоценоз влагалища и полиморфизм генов цитокинов как маркер здоровья женщины (обзор литературы). Гинекология. 2015; 17 (2): 4–13. [Prilepskay V.N., Letunovskaya A.B, Donnykov A.E. Vaginal microbiocenosis and citocine genes polymorphism as the female health marker (literature review)]. // Ginecology. 2015. Vol. 17. N2. P. 4–13]
6. Будиловская О. В., Шипицына Е. В., Герасимова Е. Н., Сафронова М. М., Савичева А. М. Видовое разнообразие вагинальных лактобацилл в норме и при дисбиотических состояниях. Журнал акушерства и женских болезней. 2017. Т. 66. № 2. С. 24–32. [Budilovskaya O.V., Shipitsyna E.V., Gerasimova E.N., Safronova M.M., Savicheva A.M.. Species diversity of vaginal lactobacilli norm and dysbiotic states. // Journal of Obstetrics and Women’s Diseases. 2017. Vol. 66. N2. P. 24–32]
7. Bagshaw S. The combined oral contraceptive. Risks and adverse effects in perspective. // Drug Saf. 1995. Vol. 12. N2. P. 91–96.
8. Chappell C. Rohan L., Wang L. et al. The effects of reproductive hormones on the viscosity and PH of cervicovaginal fluid. // Contraception. 2013. Vol. 88. N3. P. 457.
9. Vodstrcil L.A., Hocking J.S., Law M. et al. Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. // PloS One. 2013. Vol. 8. N9. e73055.
10. Brooks J. P., Edwards D. J., Blithe D. L. et al. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. // Contraception. 2017. Vol. 95. N4. P. 405–413.
11. De Seta F. Effects of estroprogestins, containing natural estrogen on vaginal flora. / F. De Seta, S. Restaino, R. Banco [et al.]. // Gynecol. Endocrinol. 2014. Vol. 30. N11. P. 830–835.
12. North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. // Menopause. 2007. Vol. 14. N 3. Pt 1. P. 355–369.
Review
For citations:
Gabidullina R.I., Galimyanova E.I., Sharapova A.M., Bagirli R.R. Effect of combined oral contraceptive containing 17β-estradiol on vaginal environment in women. Medical alphabet. 2020;(26):53-56. (In Russ.) https://doi.org/10.33667/2078-5631-2020-26-53-56
Views:
247
Email this article 